Ovid Therapeutics Inc.OVIDEarnings & Financial Report
Nasdaq · Health Care · Pharmaceutical Preparations
Top Holders
| Holder | % Owned | Shares | Change | As of |
|---|---|---|---|---|
| Jeremy M. Levin | 9.40% | 6.9M | — | 2024-02-14 |
| Rubric Capital Management LP | 7.52% | 5.3M | — | 2024-02-12 |
| BlackRock, Inc. | 6.10% | 4.3M | — | 2024-01-29 |
| NOS. OF ABOVE PERSONS | 5.20% | 3.6M | ▲ +0.10pp | 2024-02-14 |
| Biotechnology Value Fund, L.P. | 2.80% | 2.0M | — | 2024-11-14 |
| EcoR1 Capital, LLC | 0.00% | 690.5M | — | 2024-11-14 |
Insider Transactions
Net 90d: −$29.3K · buys $0 / sells $29.3KRange:
Action:
Role:
| Insider | Role | Action | ||||
|---|---|---|---|---|---|---|
| 2026-04-07 | Bart Friedman | Director | Grant | 8.8K | $2.56 | $22.5K |
| 2026-04-07 | Fitzgerald Kevin Joseph | Director | Grant | 17.6K | $2.56 | $45.0K |
| 2026-04-07 | PAPADOPOULOS STELIOS | Director | Grant | 17.6K | $2.56 | $45.0K |
| 2026-03-23 | LEVIN JEREMY M | Executive Chairman | Option exercise | 47.3K | $1.40 | $66.3K |
| 2026-02-26 | Rona Jeffrey A | CBFO | Grant | 68.1K | $0.00 | $0 |
| 2026-02-23 | ALEXANDER MARGARET A. | President and CEO | Sell (open market) | 11.7K | $1.45 | $16.9K |
| 2026-02-23 | Rona Jeffrey A | CBFO | Sell (open market) | 8.5K | $1.45 | $12.4K |
1–7 of 7